Go Deep
Standard BioTools Inc.
Standard BioTools Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 21,863 | -5.1 | 0.48 | 0.05 | 62.36 |
| Oct 2026 | 21,959 | -4.8 | 0.46 | 0.05 | 59.58 |
| Oct 2026 | 20,113 | -4.9 | 0.47 | 0.05 | 61.00 |
| Oct 2026 | 20,132 | -4.9 | 0.46 | 0.05 | 60.43 |
| Oct 2026 | 20,091 | -5.0 | 0.47 | 0.05 | 61.48 |
| Oct 2026 | 20,138 | -4.9 | 0.46 | 0.05 | 59.99 |
Standard BioTools Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 20,104,000.0 | 21,146,000.0 | 23,795,000.0 | 19,552,000.0 |
| Net Profit | -26,758,000.0 | 127,068,000.0 | 19,283,000.0 | -34,687,000.0 |
| EPS | -0.1 | 0.3 | 0.1 | -0.1 |
Standard BioTools Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 85,331,000.0 | 91,008,000.0 | 106,340,000.0 | 97,948,000.0 | — |
| Net Profit | -74,896,000.0 | -138,885,000.0 | -74,656,000.0 | -190,098,000.0 | — |
| EPS | -0.2 | -0.5 | -0.9 | -2.4 | — |
Standard BioTools Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 567,754,000.0 | 612,345,000.0 | 323,067,000.0 | 390,310,000.0 | — |
| Total Liabilities | 143,463,000.0 | 140,623,000.0 | 471,118,000.0 | 471,777,000.0 | — |
| Total Equity | 424,291,000.0 | 471,722,000.0 | -148,051,000.0 | -81,467,000.0 | — |
Owes vs Owns
Standard BioTools Inc. owed $0.14 for every $1 it owned in Jun 2026, down from $1.21 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.14× | 0.25× | 0.23× | 1.46× | 1.21× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Standard BioTools Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 33.0%Receivables 2.4%Inventory 3.5%Fixed assets (tangible) 8.1%Long-term investments 4.5%Other assets 48.4%
How it's funded — Dec 2025
Short-term debt 1.0%Payables 1.0%Other liabilities 23.3%Shareholders' equity 74.7%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 187.6 | 292.9 | 114.9 | 165.8 |
| Receivables | 13.4 | 14.7 | 19.7 | 17.3 |
| Inventory | 20.0 | 20.7 | 20.5 | 21.5 |
| Fixed assets (tangible) | 46.0 | 49.3 | 54.9 | 59.5 |
| Intangible assets | 0.0 | 140.3 | 107.7 | 118.9 |
| Long-term investments | 25.7 | 0.0 | 0.0 | 0.0 |
| Other assets | 275.1 | 94.4 | 5.4 | 7.4 |
| Liabilities & equity | ||||
| Short-term debt | 5.5 | 4.8 | 59.5 | 2.1 |
| Long-term debt | 0.3 | 0.3 | 4.0 | 62.8 |
| Payables | 5.4 | 5.0 | 9.2 | 7.9 |
| Other liabilities | 132.3 | 130.5 | 398.4 | 399.0 |
| Shareholders' equity | 424.3 | 471.7 | -148.1 | -81.5 |
| Net tangible assets | 424.3 | 471.7 | -255.8 | -200.3 |
Standard BioTools Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -74,343,000.0 | -143,454,000.0 | -43,287,000.0 | -89,370,000.0 | — |
| Investing Activities | 27,409,000.0 | 363,174,000.0 | 20,237,000.0 | -88,127,000.0 | — |
| Financing Activities | 570,000.0 | -102,616,000.0 | -6,809,000.0 | 230,758,000.0 | — |